Nektar buys Aerogen to expand into inhaled liquids
Nektar Therapeutics is planning to buy fellow drug delivery specialist Aerogen for $32 million (€26m), boosting its position in respiratory technologies.
Archives for August 15, 2005
Rhodia writes off former Chirex assets
French chemicals company Rhodia has effectively written off the value of its troubled Rhodia Pharma Solutions division in its second quarter accounts, giving it a book value of zero.
Lab studies demonstrate nerve regeneration
US researchers have made a bold claim by announcing that after successful laboratory experiments, growth, repair and return of nerve cell function has been achieved. If substantiated, the discovery is set to open up a plethora of lab research avenues.
rap. ID identifies particles in new laboratories
Micro-particle specialists, rap.ID, are set to expand its new laboratory premises to meet the demands of contamination-free particle identification. The move is in response to the increase in demand for qualified particle counts and identification in...
Japan approves drug delivery technology
CyDex has won the first regulatory approval in Japan for a pharmaceutical product using its Captisol drug delivery technology designed to improve the delivery of insoluble and unstable active pharmaceutical ingredients.